Reversal of diabetes associated with escape of myeloma: evidence for inappropriate IGF-II secretion.
We report the sudden and dramatic reversal of maturity onset diabetes in a 57-year-old woman in association with relapse of IgA myeloma diagnosed 3 years earlier. Prior to the relapse of the myeloma, twice daily insulin had been administered at a dose which had been stable for 3 years. However, the same dose produced hypoglycaemic coma at the time of relapse and, subsequently, blood glucose was controlled by diet alone. There had been no significant change in weight or renal function prior to the hypoglycaemic episode. Investigations showed a suppressed fasting serum insulin level in association with an inappropriately high serum level of IGF-II compared with IGF-I and a 'big' IGF-II concentration at the upper end of the normal range. Pituitary, adrenal and liver disease, as well as the autoimmune insulin syndrome, were excluded. The findings are consistent with the hypothesis that the plasma cell tumour was associated with excessive production of insulin-like peptides with consequent reduction in the blood glucose level.
Snowden
J A
JA
Department of Haematology, Royal Hallamshire Hospital, Sheffield.
Greaves
M
M
Page
K
K
D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007328:Insulin / Q000009:adverse effects / Q000097:blood; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications; D012008:Recurrence
D007328:Insulin; D007335:Insulin-Like Growth Factor II